| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/13/2006 | CA2581196A1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 04/13/2006 | CA2581190A1 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | CA2580529A1 Fine particle-containing composition and manufacturing method therefor |
| 04/13/2006 | CA2578449A1 Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 04/12/2006 | EP1645597A1 Conjugate of fine porous particles with polymer molecules and utilization thereof |
| 04/12/2006 | EP1645580A2 Polyureas |
| 04/12/2006 | EP1645568A1 Functional starch powder |
| 04/12/2006 | EP1645292A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645291A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645290A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645289A1 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1645287A2 Anhydrous topical skin preparations |
| 04/12/2006 | EP1645277A1 Stable tetrodotoxin freeze drying medicinal preparation |
| 04/12/2006 | EP1645267A2 Method for producing an active ingredient concentrate and active ingredient concentrate |
| 04/12/2006 | EP1645266A1 Aqueous suspension for nasal drops |
| 04/12/2006 | EP1644941A1 Magnetic nanoparticles having improved magnetic properties |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644046A2 Conjugated complement cascade inhibitors |
| 04/12/2006 | EP1644045A1 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
| 04/12/2006 | EP1644030A1 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 04/12/2006 | EP1644019A1 Abuse resistant amphetamine compounds |
| 04/12/2006 | EP1644010A2 Colloidal silver composition having antimicrobial properties |
| 04/12/2006 | EP1643959A2 Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment |
| 04/12/2006 | EP1441689B1 Solid oral compositions |
| 04/12/2006 | EP1439945B1 A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1299089B1 Drug delivery system for poorly water soluble drugs |
| 04/12/2006 | EP1294368A4 Management of snoring by oral administration of dimethyl sulfone |
| 04/12/2006 | EP1233767B1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2006 | EP1202639B1 Method for suppressing appetite |
| 04/12/2006 | EP1200040B1 Two-component composition for cosmetic or pharmaceutical use |
| 04/12/2006 | EP1152749B1 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 04/12/2006 | EP1146851B1 Galenic formulation containing biotin |
| 04/12/2006 | EP1140250B1 Device for preparing a medical fluid |
| 04/12/2006 | EP1019030A4 Method for making a multi-stage drug delivery system |
| 04/12/2006 | EP1009387B1 Stabilized sustained release tramadol formulations |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | CN1758924A Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy |
| 04/12/2006 | CN1758922A Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 04/12/2006 | CN1758911A Liquid pharmaceutical formulations of palonosetron |
| 04/12/2006 | CN1758902A Cataplasm base and cataplasm using the same |
| 04/12/2006 | CN1758899A Dosage form having a saccharide matrix |
| 04/12/2006 | CN1757662A Interpenetrating network polymer type super porous aquogel, its prepn. method and application |
| 04/12/2006 | CN1757414A Method for preparing visible polysaccharide membrane used as carrier of medicine for treating eye surface diseases |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250299C Implant with cavities containing therapeutic agents |
| 04/12/2006 | CN1250293C Drug composites |
| 04/12/2006 | CN1250292C Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/12/2006 | CN1250291C Stabilised pharmaceutical compositions and process for their preparation comprising antibiotic and expectorant |
| 04/12/2006 | CN1250282C Stable protein compositions |
| 04/12/2006 | CN1250279C Liposome targeting of matrix metalloproteinase inhibitors |
| 04/12/2006 | CN1250221C Treatment of female sexual dysfunction |
| 04/12/2006 | CN1250219C Pharmaceutical composition |
| 04/12/2006 | CN1250207C 4, 4-diaryl butadienes compound and use of ultraviolet-ray filtering agent |
| 04/12/2006 | CN1250206C Adhesive patch |
| 04/12/2006 | CN1250205C Granular preparations for oral administration |
| 04/12/2006 | CN1250204C Physical stable spraying gel composition |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026488 A hemeoxygenase inhibitory metalloprotoporphyrin derivative, especially Zn-protoporphyrin, conjugated with an amphipathic or water soluble polymer; anticarcinogenic agents with little side effect and excellent tumor accumulation; very potent and efficient; administered by intravenous injection; stability |
| 04/11/2006 | US7026440 Branched water soluble polymers containing atleast two arms, such as polyoxyethylene glycol, linked to a central aliphatic hydrocarbon core molecule through heteroatom linkage and one functional group for reacting biological active agent |
| 04/11/2006 | US7026431 Sustained release ionic conjugate |
| 04/11/2006 | US7026374 Injectable microdispersions for medical applications |
| 04/11/2006 | US7026361 Dispersion stability; forming protective colloid; bioavailability; hypotensive agents, oral diseases |
| 04/11/2006 | US7026360 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 04/11/2006 | US7026350 Water-soluble drugs and methods for their production |
| 04/11/2006 | US7026337 Gel formulations of hydroxypyridone derivatives, which contain solvents and hydrophilic gel-forming agents make possible a high release of the active compound |
| 04/11/2006 | US7026290 surfactant; an amphiphilic solvent comprising a lower alkyl hydroxy alkanoic acid ester or an N-alkyl pyrrolidone; and a cyclosporin; capable of forming particles of a size of less than about 100 nm upon contact with an aqueous solution |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026285 Immunomodulating polymers |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | US7025991 Nanoparticle drug delivery |
| 04/11/2006 | US7025990 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/11/2006 | US7025988 Forming dehydration-rehydration vesicles with lipophilic drug paclitaxel, dissolving sugar into the aqueous suspension; drug delivery of antitumor treatment |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | US7025985 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 04/11/2006 | US7025984 Controlling appetite; using ethyl oleate |
| 04/11/2006 | US7025983 Water soluble film forming polymer |
| 04/11/2006 | US7025978 Use of polysiloxanes containing quarternary amino groups as formulation auxiliary agents, and agents containing the same |
| 04/11/2006 | US7025975 Galenical formulations |
| 04/11/2006 | US7025973 Acid cosmetic, dermatological and pharmaceutical agents |
| 04/11/2006 | US7025965 Method of use and dosage composition of bluegreen algae extract for inflammation in animals |
| 04/11/2006 | US7025290 Generation of therapeutic microfoam |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2335582C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2006 | CA2321177C Recombinant fibronectin-based extracellular matrix for wound healing |
| 04/11/2006 | CA2317549C Composition for enhancing transport through lipid-containing membranes, and uses thereof |
| 04/11/2006 | CA2178632C Pharmaceutical compositions containing hiv protease inhibitors |
| 04/07/2006 | CA2522152A1 Transdermal and transmucosal preparations |
| 04/06/2006 | WO2006037116A2 Semi-solid delivery vehicle and pharmaceutical compositions |
| 04/06/2006 | WO2006037090A2 Drug-phosphate conjugates as prodrugs |
| 04/06/2006 | WO2006037070A2 Stabilization of alum-adjuvanted immunologically active agents |
| 04/06/2006 | WO2006036909A1 An antimicrobial silver halide composition |
| 04/06/2006 | WO2006036766A2 Hypoallergenic food composition |
| 04/06/2006 | WO2006036614A2 A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
| 04/06/2006 | WO2006036557A1 Delivery system for topically applied compounds |
| 04/06/2006 | WO2006035977A1 Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
| 04/06/2006 | WO2006035923A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |